ATAGI recommends a dose of COVID-19 vaccine for adults aged ≥75 years every 6 months.
ATAGI recommends the following groups receive a dose of COVID-19 vaccine every 12 months, and can consider a dose every 6 months, based on a risk-benefit assessment:
- Adults aged 65—74 years
- Adults aged 18—64 years with severe immunocompromise
The following groups can consider a COVID-19 vaccine every 12 months, based on a risk-benefit assessment:
- All other adults aged 18—64 years
- Children and adolescents aged 5—<18 years with severe immunocompromise
